Letermovir is indicated for prophylaxis of cytomegalovirus (CMV) reactivation and disease in adult CMV-seropositive recipients [R+] of an allogeneic haematopoietic stem cell transplant (HSCT).
Letermovir is indicated for prophylaxis of CMV disease in CMV-seronegative adults who have received a kidney transplant from a CMV-seropositive donor [D+/R-].
Consideration should be given to official guidance on the appropriate use of antiviral agents.
Registration
NCE
OLIMEL N12E
Glucose With Calcium Solution, Amino Acid With Electrolytes Solution And Lipid Emulsion,Glucose With Calcium Solution,Amino Acid With Electrolytes Solution,Lipid Emulsion
Glucose With Calcium Solution, Amino Acid With Electrolytes Solution And Lipid Emulsion,Glucose With Calcium Solution,Amino Acid With Electrolytes Solution,Lipid Emulsion
الاستخدامات الطبية المعتمدة
OLIMEL N12E is indicated for parenteral nutrition for adults and children greater than 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.
For the relief of the symptoms of allergic rhinitis with nasal congestion when both the antiallergic properties of fexofenadine hydrochloride and the decongestant activity of pseudoephedrine hydrochloride are required.
Calcium folinate is indicated:
• To diminish the toxicity and counteract the action of folic acid antagonists such as methotrexate in cytotoxic therapy and overdose in adults and children. In cytotoxic therapy, this procedure is commonly known as “Calcium Folinate Rescue”;
• In combination with 5-fluorouracil in cytotoxic therapy.
For adult patients with type 2 diabetes mellitus:
Sitavia-MET is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately
controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination
of sitagliptin and metformin.
Sitavia-MET is indicated in combination with a sulphonylurea (i.e., triple combination therapy) as an adjunct to
diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a
sulphonylurea.
Sitavia-MET is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma
(PPARγ) agonist (i.e., a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled
on their maximal tolerated dose of metformin and a PPARγ agonist.
Sitavia-MET is also indicated as add-on to insulin (i.e., triple combination therapy) as an adjunct to diet and
exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide
adequate glycaemic control.
Calcium folinate is indicated:
• To diminish the toxicity and counteract the action of folic acid antagonists such as methotrexate in cytotoxic therapy and overdose in adults and children. In cytotoxic therapy, this procedure is commonly known as “Calcium Folinate Rescue”;
• In combination with 5-fluorouracil in cytotoxic therapy.
